acute promyelocytic leukemia
Survey Highlights Concerning Lack of Availability of ATRA for APL
Only 42% of institutions that treat acute leukemia patients and 31% of hospitals overall in the United States have ...
FEBRUARY 18, 2022
Trisenox Receives Indication for First-Line Treatment of APL
The FDA has approved the use of arsenic trioxide (Trisenox, Teva) injection in combination with tretinoin for the ...
JANUARY 19, 2018
Load more